BlackRock’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$341K Sell
179,228
-201,782
-53% -$383K ﹤0.01% 4458
2025
Q1
$2.7M Buy
381,010
+12,322
+3% +$87.4K ﹤0.01% 3855
2024
Q4
$8.11M Sell
368,688
-5,001
-1% -$110K ﹤0.01% 3484
2024
Q3
$7.5M Buy
373,689
+17,824
+5% +$358K ﹤0.01% 3503
2024
Q2
$6.19M Buy
355,865
+64,669
+22% +$1.13M ﹤0.01% 3561
2024
Q1
$12.1M Buy
291,196
+10,612
+4% +$443K ﹤0.01% 3194
2023
Q4
$7.06M Buy
280,584
+8,689
+3% +$219K ﹤0.01% 3481
2023
Q3
$8.89M Sell
271,895
-31,281
-10% -$1.02M ﹤0.01% 3353
2023
Q2
$17.6M Buy
303,176
+291,723
+2,547% +$17M ﹤0.01% 3050
2023
Q1
$299K Buy
11,453
+2,297
+25% +$60K ﹤0.01% 4590
2022
Q4
$273K Sell
9,156
-490
-5% -$14.6K ﹤0.01% 4681
2022
Q3
$494K Buy
9,646
+398
+4% +$20.4K ﹤0.01% 4645
2022
Q2
$268K Buy
9,248
+188
+2% +$5.45K ﹤0.01% 4866
2022
Q1
$476K Sell
9,060
-92
-1% -$4.83K ﹤0.01% 4793
2021
Q4
$628K Buy
9,152
+204
+2% +$14K ﹤0.01% 4735
2021
Q3
$1.42M Buy
8,948
+172
+2% +$27.3K ﹤0.01% 4396
2021
Q2
$1.71M Sell
8,776
-27,616
-76% -$5.38M ﹤0.01% 4273
2021
Q1
$9.4M Buy
36,392
+1,942
+6% +$502K ﹤0.01% 3551
2020
Q4
$6.65M Buy
34,450
+1,577
+5% +$304K ﹤0.01% 3500
2020
Q3
$6.68M Buy
32,873
+438
+1% +$89K ﹤0.01% 3360
2020
Q2
$9.07M Buy
32,435
+3,250
+11% +$909K ﹤0.01% 3175
2020
Q1
$8.76M Buy
29,185
+2,532
+9% +$760K ﹤0.01% 3021
2019
Q4
$8.55M Buy
26,653
+3,089
+13% +$991K ﹤0.01% 3274
2019
Q3
$8.98M Buy
23,564
+8,347
+55% +$3.18M ﹤0.01% 3225
2019
Q2
$6.85M Buy
15,217
+13,888
+1,045% +$6.25M ﹤0.01% 3387
2019
Q1
$694K Sell
1,329
-83
-6% -$43.3K ﹤0.01% 3977
2018
Q4
$589K Buy
1,412
+153
+12% +$63.8K ﹤0.01% 3999
2018
Q3
$368K Buy
1,259
+16
+1% +$4.68K ﹤0.01% 4123
2018
Q2
$812K Buy
1,243
+265
+27% +$173K ﹤0.01% 3915
2018
Q1
$4.03M Buy
+978
New +$4.03M ﹤0.01% 3444